Tenon Medical, Inc. Equity Restrictions
Tenon Medical, Inc. (TNON) had Equity Restrictions of $2.50 million as of 2023-07-16, per its 10-Q filed 2023-08-11.
Discontinued › Notes › Equity
us-gaap:EquityRestrictions · last filed 2023-08-11
- 2023-07-16: Equity Restrictions $2.50M.
| Period end | Equity Restrictions |
|---|---|
| 2023-07-16 | $2.50M 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |